TCEAL1
Basic information
Region (hg38): X:103628704-103630953
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder with gait disturbance, dysmorphic facies, and behavioral abnormalities, X-linked (Moderate), mode of inheritance: XL
- neurodevelopmental disorder with gait disturbance, dysmorphic facies, and behavioral abnormalities, X-linked (Strong), mode of inheritance: XL
- neurodevelopmental disorder with gait disturbance, dysmorphic facies, and behavioral abnormalities, X-linked (Moderate), mode of inheritance: XL
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Hijazi-Reis syndrome (Neurodevelopmental disorder with gait disturbance, dysmorphic facies and behavioral abnormalities, X-linked) | XL | Allergy/Immunology/Infectious | In addition to other features, recurrent infections have been described (including respiratory and ear infections), and awareness may allow early and aggressive treatment of infections | Allergy/Immunology/Infectious; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic | 36368327 |
ClinVar
This is a list of variants' phenotypes submitted to
- Neurodevelopmental_disorder_with_gait_disturbance,_dysmorphic_facies,_and_behavioral_abnormalities,_X-linked (13 variants)
- Inborn_genetic_diseases (10 variants)
- not_provided (7 variants)
- See_cases (6 variants)
- not_specified (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TCEAL1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004780.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | |||||
| missense | 12 | 15 | ||||
| nonsense | 6 | |||||
| start loss | 0 | |||||
| frameshift | 7 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 1 | 10 | 15 | 4 | 0 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| TCEAL1 | protein_coding | protein_coding | ENST00000372625 | 1 | 2250 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.586 | 0.376 | 122593 | 1 | 0 | 122594 | 0.00000408 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.04 | 35 | 57.3 | 0.611 | 0.00000383 | 1056 |
| Missense in Polyphen | 12 | 17.187 | 0.69821 | 289 | ||
| Synonymous | -0.0328 | 21 | 20.8 | 1.01 | 0.00000133 | 290 |
| Loss of Function | 1.53 | 0 | 2.73 | 0.00 | 1.72e-7 | 63 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00 | 0.00 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.000126 | 0.0000468 |
| European (Non-Finnish) | 0.00 | 0.00 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in transcriptional regulation. Modulates various viral and cellular promoters in a promoter context- dependent manner. For example, transcription from the FOS promoter is increased, while Rous sarcoma virus (RSV) long terminal repeat (LTR) promoter activity is repressed. Does not bind DNA directly.;
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- rvis_EVS
- 0.08
- rvis_percentile_EVS
- 59.43
Haploinsufficiency Scores
- pHI
- 0.0528
- hipred
- Y
- hipred_score
- 0.574
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.988
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tceal1
- Phenotype
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II
- Cellular component
- nucleus;nucleoplasm
- Molecular function
- DNA-binding transcription factor activity;WW domain binding